A great pitch = -non-consensus idea -great team -big market -window of opportunity + crucial founder "intangibles" Few admit how vital these intangibles are. Today, Omri Amirav-Drory pulls back the curtain: https://lnkd.in/eVE7skjQ
NFX
Venture Capital and Private Equity Principals
San Francisco, California 26,223 followers
NFX is a venture firm exclusively focused on pre-seed & seed stage startups.
About us
NFX is a venture firm exclusively focused on pre-seed & seed stage startups.
- Website
-
http://www.nfx.com
External link for NFX
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 11-50 employees
- Headquarters
- San Francisco, California
- Type
- Partnership
- Founded
- 2017
- Specialties
- Network Effects, Product Design, Growth, Positioning & Branding, Strategy, and Code of Confidentiality
Locations
-
Primary
32 Page St
San Francisco, California 94102, US
-
Herzlia, Israel, IL
Employees at NFX
Updates
-
Every technology offers a fleeting window of opportunity to launch a successful company. Timing is crucial: get it right and it can make your career; miss it, and it becomes 90% harder James Currier on how to recognize these windows: https://lnkd.in/ewT-4u9u
Technology Windows: The Unseen Force Driving Your Startup
nfx.com
-
The economics of launch are clear: the potential is massive. Today, Morgan Beller looks at how a new generation of founders is poised to thrive in the growing space economy: https://lnkd.in/e9mqZDQr
An Ode to Launch
nfx.com
-
Two NFX FAST funding competitions are open! -NFX FAST Forward: for Israeli startups in space, cyber, defense tech, DevOps AI, longevity, fintech, & vertical AI. -NFX Longevity FAST: for scientist-founders focused on aging. $1.5M - $3M SAFE investment depending on FAST type. Decisions in 9 days. Applications and details below: FAST is a new SLA for fundraising. -$20M allocated. First come, First serve -Money in your bank in 3 weeks -A simple financial contract -Transparent process Apply to NFX FAST Forward: https://lnkd.in/es36WrNC Apply to NFX Longevity FAST: https://lnkd.in/eHJyNtmc
-
FAST LITE is officially open! FAST LITE is a funding competition open to students/alumni from from Harvard, Stanford, Berkeley, and MIT. Winners receive $50-$100K checks and feedback on their ideas from NFX partners. Apply below: Harvard FAST Lite: bit.ly/harvardfastlite Stanford FAST Lite: bit.ly/stanfordfastlite Berkeley FAST Lite: bit.ly/berkeleyfastlite MIT FAST Lite: bit.ly/mitfastlite
-
Meet the 2025 NFX Fellows. From a pool of 300+ applicants from Stanford, Berkeley, MIT, and Harvard, we've chosen top operators and investors ready to back their peers at the earliest stage. This year, we're going to hit the ground running... https://lnkd.in/eC8erJmT This Friday (11/1) we're launching FAST LITE: an early version of our spring FAST competition. Winners receive $50K – $100K checks, and the opportunity to receive feedback from NFX Partners. FAST LITE is designed to support student/alumni founders from Harvard, Stanford, Berkeley and MIT with ideas at the earliest stages. Applications open 11/1. Watch this space for updates. Get up to speed on FAST LITE in our post above. Or reach out to an NFX Fellow to learn more.
Meet the 2025 NFX Fellows
nfx.com
-
The bar for raising series A as a techbio platform is high. You have to have a strategy. The key is to balance platform + asset development. One propels the other. Omri Amirav-Drory's tactics for reaching key Series A milestones as a bioplatform: https://lnkd.in/eMEHKCdp
Why Great Bioplatforms Will Always Win
nfx.com
-
Congratulations to our portco Centivax on advancing Cent-Flu, their universal flu vaccine, into GMP manufacturing. Cent-Flu aims to protect against all past, present, and future influenza strains This is a critical critical milestone in the fight against infectious disease. Congrats again to the whole team: https://lnkd.in/djUSwUiH
Centivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing of Revolutionary Universal Influenza Vaccine
prnewswire.com
-
Please join us in congratulating Daniel Museles on his promotion to Principal at NFX. Daniel will probably find you first, but if you’re working on something early and wacky, reach out to him! https://lnkd.in/dPXZy3qf
Promoting Daniel Museles to Principal
nfx.com
-
The best investors "see what others do not" because they have a fresh POV. Where would tech be without builders-turned-investors? Would TechBio exist without scientist-investors? A candid take from Omri Amirav-Drory why more investors = more breakthroughs: https://lnkd.in/eTqEJzVv
How to Start Your Own VC Fund
nfx.com